marstacimab-hncq — Blue Cross Blue Shield of Texas
Off-label indications for BCBS MT Fully Insured/HIM members or NM/Ohio exceptions per policy
Initial criteria
- Request for BCBS MT Fully Insured or MT HIM member AND:
- Patient age <18 years AND no FDA labeled contraindications AND
- Indication supported in TWO major peer-reviewed medical journal articles as generally safe and effective (not case studies) AND
- Support for patient's age bracket (infancy, childhood, adolescence) in same literature
- OR Request for BCBS NM Fully Insured or NM HIM member AND:
- No FDA labeled contraindications AND requested indication is a rare disease AND
- Patient has another FDA labeled or compendia-supported indication OR
- Two peer-reviewed journal articles support use as generally safe and effective (not case studies)
- OR request for Ohio Fully Insured or HIM Shop member AND same journal/comprendia criteria
Approval duration
BCBSOK: 36 months; all other: 12 months